Development of a novel remote patient monitoring system : the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy by Maguire, Roma et al.
Research Archive
Citation for published version:
Roma Maguire, et al, ‘Development of a novel remote patient 
monitoring system: the advanced symptom management 
system for radiotherapy to improve the symptom experience of 
patients with lung cancer receiving radiotherapy’, Cancer 
Nursing, vol. 38 (2): E37-47, May 2014.
DOI:
https://doi.org/10.1097/NCC.0000000000000150
Document Version:
This is the Accepted Manuscript version. 
The version in the University of Hertfordshire Research Archive 
may differ from the final published version. 
Copyright and Reuse: 
© 2014 Wolters Kluwer.
Content in the UH Research Archive is made available for 
personal research, educational, and non-commercial purposes 
only. Unless otherwise stated, all content is protected by 
copyright, and in the absence of an open license, permissions 
for further re-use should be sought from the publisher, the 
author, or other copyright holder. 
Enquiries
If you believe this document infringes copyright, please contact the 
Research & Scholarly Communications Team at rsc@herts.ac.uk
CANCER NURSING: An International Journal for Cancer Care
 
Development of A Novel Remote Patient Monitoring System to Improve the Symptom
Experience of Patients with Lung Cancer Receiving Radiotherapy: The Advanced
Symptom Management System for Radiotherapy (ASyMS-R)
--Manuscript Draft--
 
Manuscript Number: CN-D-13-00204R1
Full Title: Development of A Novel Remote Patient Monitoring System to Improve the Symptom
Experience of Patients with Lung Cancer Receiving Radiotherapy: The Advanced
Symptom Management System for Radiotherapy (ASyMS-R)
Short Title: Advanced Symptom Management System for Radiotherapy (ASyMS-R)for Patients
with Lung Cancer
Article Type: Original Research Study
Keywords: Lung Cancer;  Radiotherapy;  Supportive Care;  Technology;  E-Health;  ASyMS
Corresponding Author: Roma Maguire, PhD, MSc (Med. Sci), BN, RGN
University of Surrey
UNITED KINGDOM
Corresponding Author Secondary
Information:
Corresponding Author's Institution: University of Surrey
Corresponding Author's Secondary
Institution:
First Author: Roma Maguire, PhD, MSc (Med. Sci), BN, RGN
First Author Secondary Information:
Order of Authors: Roma Maguire, PhD, MSc (Med. Sci), BN, RGN
Emma Ream, PhD, MSc, BSc, RN, PG Dip Acad Practice
Alison Richardson, PhD, MSc, BN (Hons), Pg Dip Ed, RNT
John Connaghan, MSc, MA (Hons)
Bridget Johnston, PhD, BN (Hons), PGCE (FE), RN
Grigorios Kotronoulas, PhD, MSc (Oncol Nurs & Palliat Care), BSN
Vibe Pedersen, MSc (Anth), MSc (HTA)
John McPhelim, BSc Hon (Nursing), RGN
Natalie Pattison, DNSc, MSc, BSc (Hons), RN, Dip Onc.
Allison Smith, MN (Cancer), RN
Lorraine Webster, BSc (Hons), DCRT (T), Dip Couns, Cert Couns
Anne Taylor, PhD, BSc (Hons), RGN
Nora Kearney, MSc, RGN
Order of Authors Secondary Information:
Manuscript Region of Origin: UNITED KINGDOM
Abstract: Background: The use of technology-enhanced patient-reported outcome measures
(PROMs) to monitor the symptoms experienced by people with cancer is an effective
way to offer timely care. Objective: This study aimed to (a) explore the feasibility and
acceptability of the Advanced Symptom Management System with patients with lung
cancer receiving radiotherapy (ASyMS-R), and clinicians involved in their care; and (b)
assess changes in patient outcomes during implementation of ASyMS-R in clinical
practice. Methods: A repeated-measures, single-arm, mixed-methods study design
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
was utilized, involving post-study interviews and completion of PROMs at baseline and
end of treatment with 16 patients with lung cancer and 13 clinicians who used this
mobile phone-based, symptom monitoring system. Results: Only rarely did patients
report problems in using the handset, while they felt that the system covered all
relevant symptoms and helped them to manage their symptoms and effectively
communicate with clinicians. Clinical improvements in patient anxiety, drowsiness, and
self-care self-efficacy were also observed. Clinicians perceived the use of 'real-time'
risk algorithms and automated self-care advice provided to patients as positively
contributing to clinical care. Reducing the complexity of the system was seen as
important to promote its utility. Conclusions: Whilst tentative, these results suggest that
monitoring patient symptoms using mobile technology in the context of radiotherapy for
lung cancer is feasible and acceptable in clinical practice. Implications for practice:
Future research should focus the use of this technology on the post-radiotherapy
phase, and widen the scope of the system to encompass a wider range of supportive
care needs.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
TITLE PAGE 
 
Complete Manuscript Title: 
Development of a novel remote patient monitoring system: the Advanced Symptom 
Management System for Radiotherapy (ASyMS-R) to improve the symptom experience of 
patients with lung cancer receiving radiotherapy 
 
Author Names: 
Roma Maguire, PhD, MSc (Med. Sci), BN, RGN 
Emma Ream, PhD, MSc, BSc, RN, PG Dip Acad Practice 
Alison Richardson, PhD, MSc, BN (Hons), Pg Dip Ed, RNT 
John Connaghan, MSc, MA (Hons) 
Bridget Johnston, PhD, BN (Hons), PGCE (FE), RN 
Grigorios Kotronoulas, PhD, MSc (Oncol Nurs & Palliat Care), BSN 
Vibe Pedersen, MSc (Anth), MSc (HTA) 
John McPhelim, BSc Hon (Nursing), RGN 
Natalie Pattison, DNSc, MSc, BSc (Hons), RN, Dip Onc. 
Allison Smith, MN (Cancer), RN 
Lorraine Webster, BSc (Hons), DCRT (T), Dip Couns, Cert Couns 
Anne Taylor, PhD, BSc (Hons), RGN 
Nora Kearney, MSc, RGN 
 
Author Affiliations: 
School of Health and Social Care, University of Surrey, Guildford, Surrey, United Kingdom 
(Professor Maguire, Dr. Kotronoulas and Professor Kearney); School of Nursing & 
Title Page
Midwifery, University of Dundee, Dundee, United Kingdom (Mr. Connaghan); School of 
Health Sciences, University of Nottingham, Nottingham, United Kingdom (Professor 
Johnston); Florence Nightingale School of Nursing, Kings College London, London, United 
Kingdom (Professor Ream); Faculty of Health Sciences, University of Southampton and 
University Hospital Southampton NHS Foundation (Professor Richardson); NHS 
Lanarkshire, Lanarkshire, United Kingdom (Mr. McPhelim); The Royal Marsden NHS 
Foundation Trust, London, United Kingdom (Dr. Pattison); NHS Greater Glasgow and 
Clyde, Glasgow, United Kingdom (Ms. Smith); Beatson West of Scotland Cancer Centre, 
Glasgow, United Kingdom (Ms. Webster); Nursing and Midwifery Allied Health 
Professionals Research Unit, University of Stirling (Dr. Taylor); Danish Patients 
Organisation (Ms. Pedersen). 
 
Corresponding Author:  
Professor Roma Maguire, School of Health and Social Care, Faculty of Health and Medical 
Sciences, University of Surrey, Duke of Kent Building, Guildford, Surrey, GU2 7TE, United 
Kingdom 
E-mail: r.maguire@surrey.ac.uk 
Phone: +44 (0) 141 249 0921 
 
Acknowledgements/disclosures: 
This study was funded by the National Cancer Research Institute (NCRI) Supportive and 
Palliative Care Research Collaboratives (Grant ID: LCSuPaC 16). 
 
Conflict of interest statement: 
All authors declare that they have no personal or financial conflicts of interest to disclose. 
ABSTRACT 
Background: The use of technology-enhanced patient-reported outcome measures (PROMs) 
to monitor the symptoms experienced by people with cancer is an effective way to offer 
timely care. Objective: This study aimed to (a) explore the feasibility and acceptability of the 
Advanced Symptom Management System with patients with lung cancer receiving 
radiotherapy (ASyMS-R), and clinicians involved in their care; and (b) assess changes in 
patient outcomes during implementation of ASyMS-R in clinical practice. Methods: A 
repeated-measures, single-arm, mixed-methods study design was utilized, involving post-
study interviews and completion of PROMs at baseline and end of treatment with 16 patients 
with lung cancer and 13 clinicians who used this mobile phone-based, symptom monitoring 
system. Results: Only rarely did patients report problems in using the handset, while they felt 
that the system covered all relevant symptoms and helped them to manage their symptoms 
and effectively communicate with clinicians. Clinical improvements in patient anxiety, 
drowsiness, and self-care self-efficacy were also observed. Clinicians perceived the use of 
‘real-time’ risk algorithms and automated self-care advice provided to patients as positively 
contributing to clinical care. Reducing the complexity of the system was seen as important to 
promote its utility. Conclusions: Whilst tentative, these results suggest that monitoring 
patient symptoms using mobile technology in the context of radiotherapy for lung cancer is 
feasible and acceptable in clinical practice. Implications for practice: Future research 
should focus the use of this technology on the post-radiotherapy phase, and widen the scope 
of the system to encompass a wider range of supportive care needs. 
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1 
INTRODUCTION 
Lung cancer is the commonest cancer worldwide
1
, with 1.6 million people diagnosed each 
year. Survival rates are poor, with only 7-9% of people in the UK living 5 years or more
2-5
. 
Approximately 70% of people with lung cancer receive radiotherapy as a treatment option, 
with either curative or palliative intent
6
. Radiotherapy is associated with a number of 
toxicities that occur as acute or late effects, which have a negative impact on patient 
outcomes such as quality of life, symptom burden and physical functioning
7-10
. People with 
lung cancer experience a high level of supportive care needs and many of these needs are 
unmet
11-15
. Partly responsible for this is the fact that people with lung cancer tend to not seek 
help for their supportive care needs; lack of awareness of what needs are amenable to 
intervention and the assumption that many of their needs just need to be endured have been 
cited as potential reasons
16
. Systematic supportive care is therefore vital in this patient 
group
13
. 
To this end, patient-reported outcome measures (PROMs) can be utilized to identify the 
supportive care needs of people with lung cancer throughout the cancer trajectory. PROMs 
are defined as ‘measurements of an aspect of a patient’s health status that come directly from 
the patient’17 and their use has been partly instigated by the incongruence between patient and 
health professional and/or carer perceptions of health and need
18-20
. This has led to the wide 
scale agreement that patient reporting of their symptoms is the ‘gold standard’21 and that 
collection of PROM data in clinical practice has a number of beneficial effects
22
. 
Enhancing the utility of PROMs within clinical practice is the use of ‘real-time’ health 
technologies (i.e. e-health technologies), which have the ability to collect PROM data and 
send this information immediately to relevant health/social care professionals, thus initiating 
early intervention. Recently, government policy in the United Kingdom has endorsed the use 
Manuscript
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of e-health technologies to support clinical care with the ultimate goal being the promotion of 
care provided
23
 and self-care
24
 in people with long-term health conditions, including patients 
with cancer. With the recent shift from inpatient to ambulatory care, the numbers of patients 
with cancer receiving treatment on an outpatient basis have increased dramatically; this can 
be translated in more people having to manage treatment-related toxicities at home without 
direct supervision from health professionals
25
. The use of e-health technologies such as 
mobile information and ‘real-time’ communications technology may be instrumental in 
overcoming such barriers
26
. In that sense, enhancement of the care provided to people with 
cancer can be translated into reduction in symptom prevalence and/or burden and therefore 
reduction in unnecessary hospital admissions, inpatient days, or outpatient visits. 
Alternatively, promotion of self-care, namely “the ability of individuals, families and 
communities to promote health, prevent disease, and maintain health and to cope with illness 
and disability with or without the support of a health-care provider” (World Health 
Organization, 2013)
27
, can give people with cancer greater confidence and sense of control, 
and consequently enhance perceived well-being and quality of life
28
.  
The Advanced Symptom Management System (ASyMS)
29-32
 is one of the most developed 
remote patient monitoring systems that enables the ‘real-time’ collection of PROM data to 
enhance both provision of structured cancer care and patient self-care. Over the past ten 
years, the ASyMS system has been tested in several patient populations, including adults with 
breast, colorectal, lung and hematological cancers receiving chemotherapy
29-31
, teenagers 
receiving chemotherapy
28
, and people with palliative care needs
33
. These studies have 
demonstrated positive perceptions by patients and health professionals regarding the utility, 
acceptability and feasibility of the system and improvements in symptom outcomes
30
.  
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Despite the recognition of the wide spectrum of supportive care needs experienced by people 
with lung cancer during and after radiotherapy
13
, there is a lack of interventions that explore 
the use of real-time technologies in this patient population. To date, to our knowledge, only 
one study has been published on the use of e-health technology to monitor and assess the 
symptoms experienced by people with lung cancer receiving palliative radiotherapy
34
; 
however, due to low levels of recruitment, no outcomes were reported and the authors 
concluded that further research was warranted. Therefore, the primary aim of this study was 
to develop and explore the feasibility and acceptability of the ASyMS in patients with lung 
cancer receiving radiotherapy (ASyMS-R) and with clinicians involved in their care. A 
secondary aim was to explore changes in PROMs during the implementation of ASyMS-R, 
which could eventually inform the design and primary endpoints of future randomized 
controlled trials.  
 
METHODS 
A repeated measures, single-arm, mixed methods study design was utilized in this study, 
which was conducted in five clinical sites in the UK between 2008 and 2011. The current 
study was informed by the Medical Research Council Complex Interventions Framework
35
. 
e-health technological interventions are regarded as ‘complex’ because they are built up from 
a number of components that involve theoretical understanding of how the use of technology 
benefits patients, and require the involvement of multiple agencies. The MRC Framework 
proposes a cyclical, multi-method process in the evaluation of these components that takes 
place in partnership with the target population
35
. In addition, the Holistic Framework to 
improve the Uptake and Impact of e-Health Technologies developed by van Gemert-Pijnen et 
al.
36
 was used to inform the current study. According to this framework, six fundamental 
4 
working principles underpin the development of e-health technologies (Table 1). The 
framework provides comprehensive development strategies that can be used in a forward 
(development) and backward (summative evaluation) process, but is also flexible to 
accommodate for time, policy and financial challenges in clinical practice
36
.  
 
Sample and Setting 
The study aimed to recruit 45 patients with lung cancer, receiving a course of thoracic 
radiotherapy, aged >18 years and able to provide written, informed consent. This sample size 
has been advocated as adequate for feasibility/pilot studies
37
. Clinicians involved in the care 
of people with lung cancer receiving radiotherapy were also recruited at the five participating 
centers following informed consent. Ethical approval for the study was granted by the Fife 
and Forth Valley on Medical Research Ethics committee. 
 
Procedures 
Adaptation of ASyMS for use in people with lung cancer receiving radiotherapy (MRC 
Framework pre-clinical phase
35
) 
ASyMS is a mobile phone-based, remote patient monitoring system. For this study, it was 
adapted for use in people with lung cancer receiving radiotherapy via multiple methods, 
including an e-survey of toxicity assessment tools in the UK and three systematic reviews of 
the literature (i.e. symptoms experienced by people with lung cancer undergoing radiotherapy 
treatment; toxicity assessment tools; evidence-based self-care; unpublished). In addition, the 
protocols from each of the participating sites pertaining to radiotherapy toxicity assessment 
and self-care advice were also reviewed. Focus groups with clinicians caring for people with 
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lung cancer (n=2) and people with lung cancer who were currently or had recently received 
radiotherapy treatment (n=2) were also conducted. Exploring the perspectives of key users is 
advocated as being a key component in the development and testing of new technologies
38
. 
This information informed the content and adaptation of the developing ASyMS-R system, 
including (a) the selection of the daily electronic PROMs (e-PROMs) completed by patients, 
which included the Memorial Symptom Assessment Scale – Short Form (MSAS-SF)39 and 
the Rotterdam Symptom Checklist – Activity Subscale (RSC-Activity)40; (b) the risk model 
for the generation of alerts; and (c) the evidence-based self-care advice provided for 
management of toxicity.  
 
The ASyMS-R Intervention (MRC Framework modeling phase
35
) 
Participating clinicians notified the study research assistant (RA) of a new patient scheduled 
to receive radiation therapy; the RA then checked patient eligibility against inclusion and 
exclusion criteria, fully informed patients about the study’s aims and procedures, discussed 
issues of confidentiality and anonymity, and invited patients to take part in the study. All 
consenting patients provided written informed consent. 
Patients used the ASyMS-R system at home during working hours (9 AM-5 PM), seven days 
a week for the duration of their radiotherapy treatment and for one month post-treatment, and 
were instructed to follow local procedures regarding out of hours care. After completing the 
daily questionnaire on the mobile phone, patient daily symptom data was sent in ‘real time’ to 
a central study server, where an integrated risk model analyzed the symptom reports. 
Successful receipt and analysis of symptom data was followed by two actions (Figure 1). 
First, patients immediately received self-care advice on their mobile phone that was directly 
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related to the severity of their symptoms. Second, for those symptoms that were of clinical 
concern, the server generated alerts to a pager held by a health professional at the clinical site. 
The ASyMS-R system generated two types of alerts. An ‘amber alert’ was generated when 
the patient was experiencing symptoms that were not severe or life-threatening, but where 
early intervention may have prevented progression of the symptom or minimized it. A ‘red 
alert’ denoted that the patient was experiencing symptoms that were severe. Table 2 provides 
examples of symptoms and conditions used in the ASyMS-R risk models to generate amber 
or red alerts. For amber alerts, clinicians were required to contact the patient within 8 hours 
after an alert had been received; for red alerts, health professionals were required to contact 
patients as soon as possible to initiate appropriate management. Upon receipt of a new 
incoming alert, health professionals were required to log into a secure web page to access the 
patient’s symptom history in the format of symptom reports and graphs of symptoms to 
inform any clinical decisions and subsequent interventions. The health professional then 
contacted the patient over the phone to conduct a clinical assessment and offer timely advice 
and support. Any interventions initiated as a result of the alert were documented in the 
patient’s medical record and on the secure web page. No standardized clinical intervention 
protocols were used in this study; instead, health professionals were asked to make use of 
clinical intervention protocols available at their clinical site. An example scenario of a 
clinical intervention following receipt of a red alert is presented in Figure 2. 
 
Data Collection 
Perceptions of patients and health professionals of the feasibility and acceptability of 
ASyMS-R were explored using a combination of semi-structured questionnaires and semi-
structured interviews, successfully used in previous ASyMS studies
29, 31
. Semi-structured 
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questionnaires were completed pre- and post-intervention, and interviews were conducted at 
the end of the study. The content of the questionnaires and interviews focused on the 
following pre-determined themes that were relevant to both patients and health professionals: 
experience of using the technology; expectations of being involved in the ASyMS-R study 
(pre-study only); perceptions of the training received on how to use the ASyMS R system; 
and experience of using the system in clinical practice (including the e-PROMs used, the 
alerts generated and the evidence-based self-care advice provided). Participants were also 
asked about their perceptions on changes in clinical care as a result of using the ASyMS-R 
system including perceived changes in symptom management, suggestions for improving the 
system and their overall experiences of being involved in the study. Health professionals 
were also asked to grade the appropriateness of all clinical alerts received. However, how fast 
any incoming alerts were handled by health professionals or the time required for a clinician 
to fully investigate and respond to an alert was not recorded in this early version of the 
ASyMS-R system. 
To address the study’s secondary objective, patients also completed four PROMs at baseline 
and at the end of treatment to investigate changes in anxiety levels (State-Trait Anxiety 
Inventory Form Y, STAI-Y
41
); self-care self-efficacy (Strategies Used by Patients to Promote 
Health, SUPPH-29
42
); well-being and quality of life (Functional Assessment of Cancer 
Therapy-Lung Cancer, FACT-L
43
); and physical symptom distress (Edmonton Symptom 
Assessment Scale, ESAS
44
) during use of the ASyMS-R system. 
The STAI-Y was used to measure psychological distress. It consists of two 20-item scales for 
measuring state (i.e. a transitory emotional response to a stressful situation) and trait anxiety 
(i.e. personality-related predisposition to anxiety)
41
. Higher scores indicate more anxiety. The 
SUPPH-29 was used to measure perceived self-care self-efficacy. It consists of 29 items 
8 
measuring evaluate individuals’ belief in the strategies they use to improve their health. Three 
subscale (stress reduction; making decisions; and positive attitude) and a total score can be 
calculated
42
. An increase in score shows an increase in level of self-efﬁcacy related to self-
care behaviors. Disease-speciﬁc quality of life was assessed using the FACT-L scale. FACT-
L consists of ﬁve subscales: four general subscales (i.e. physical well-being [PWB], 
social/family well-being [SWB], emotional well-being [EWB], and functional well-being 
[FWB]) and a 7-item Lung Cancer Subscale (LCS) that assesses symptoms commonly 
reported by patients with lung cancer
43
. Along with a total FACT-L score, a Trial Outcome 
Index (TOI) is derived by adding scores on the PWB and FWB subscales to the LCS. Higher 
scores represent better functioning and better quality of life. Finally, the ESAS measures 
presence and severity of ten common symptoms (pain, fatigue, nausea, depression, anxiety, 
drowsiness, shortness of breath, lack of appetite, sleep disorders, and impaired feeling of 
well-being) in patients with cancer
44
. Patients are asked to rate intensity of symptoms over 
the past 24 hours using an 11-point numeric rating scale, from 0 (no symptoms) to 10 (worst 
possible symptoms). 
 
Data Analysis 
Patient and professional interviews were audio recorded and transcribed verbatim. Data was 
analyzed using thematic analysis
45
. Thematic content analysis
45
 is a useful approach for 
answering questions about the salient issues for a particular group of respondents or for 
identifying typical responses. The software analysis package QSR NVivo version 8 was used 
to aid the organization of the data. Themed categories were identified by two researchers 
based on the research objectives and questions following a deductive approach. Analysis of 
the data focused on points of convergence or divergence on issues raised by participants. For 
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reliability and validity purposes, two researchers coded interviews independently. Following 
this preliminary stage of analysis, the two coders cross-checked the codes to ensure that the 
interpretations were appropriately grounded in the data. Inter-coder agreement was achieved 
for the entire data set. 
Demographic, clinical, and perception questionnaires were calculated as frequencies (per 
cent), means, standard deviations and range. Pairwise deletion approach was used to 
effectively deal with missing data. Data were examined for normality (Shapiro-Wilk test for 
samples <50) to select between parametric or non-parametric tests. Statistical analyses for 
two (t-test or Mann-Whitney U) or more independent groups (one-way ANOVA or Kruskal-
Wallis test) were performed to identify significant associations between demographic or 
clinical variables and items on the perceptions questionnaire. Due to the small sample size, 
Fisher’s Exact tests were performed to examine differences between categorical/nominal 
variables. Paired samples t-tests (or Wilcoxon Signed Ranks tests) and McNemar tests were 
performed to test for significant differences between pre- and post-study data. IBM SPSS 
17.0 for Windows was used to aid statistical analyses. Given that this was an exploratory 
study, no adjustment for multiple statistical tests was applied. All tests were conducted with a 
two-tailed level of significance of 0.05. 
 
RESULTS 
A total of 57 patients across the five sites were approached to take part in the study. Of these, 
41 patients declined and 16 patients (response rate 28.1%) consented and participated in the 
study. Reasons for refusal included poor health status, patients feeling that they were being 
adequately managed by their clinical team and therefore perceived no need for additional 
10 
supportive care interventions and lack of familiarity with the use of technology. Such low 
rates of participation are common among people with lung cancer, those with advanced 
disease and those approaching the end of life
46-48
. No comparisons between patients who 
consented and those who refused participation could be conducted as we did not have 
permission to collect sociodemographic data from non-participants. 
Participants were predominantly female (n=11), with a mean age of 63.6 (±12.9) years, 
ranging between 42-85 years. Three out of four patients (n=12) had a good performance 
status (ECOG PS 0 or 1), with the majority (n=5) scheduled to receive five fractions of 
radiotherapy for lung cancer. Due to the progressive nature of the disease, five patients died 
before post-study assessment; thus, information was collected only from the remaining 11 
patients at this point. Due also to missing data, actual numbers of patients commenting on the 
different components of the ASyMS-R system vary. 
A total of 13 health professionals also participated in the study. The majority of health 
professionals identified themselves as Lung Cancer Nurse Specialists (n=4), Consultant 
Oncologists (n=2), Nursing Research Fellows (n=2) or other (Staff Nurse; Radiographer; 
Charge Nurse; Consultant Nurse; n=4). One health professional did not fill out the respective 
question. 
 
Primary Aim: Feasibility and Acceptability of ASyMS-R 
Over a 12-month period, a total of 182 alerts were generated during the study by the ASyMS-
R system (138 amber alerts/44 red alerts). Health professionals graded 51% of amber alerts 
and 43% of red alerts generated by ASyMS-R as being appropriate. Reasons for alerts being 
deemed as ‘inappropriate’ included no change from the patients baseline measurements; 
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patients being seen on a daily basis by health professionals involved in their care; symptoms 
pre-existing before radiotherapy treatment; other health professionals dealing with symptoms 
and symptoms improving from previous measurement. However, a few health professionals 
also spoke about the difficulties in “labelling” the alerts as appropriate or inappropriate as 
they perceived all alerts generated by the patient to be appropriate. 
During post-study interviews, 9 patients indicated that they had received enough training in 
order to use the ASyMS-R handset. Furthermore, all or almost all reported that they never or 
very rarely encountered problems in using the handset (n=10; 100%), answering and 
submitting questionnaires (n=9; 90%), reading the self-care information after submitting a 
questionnaire or again at a later date (n=10; 100%), or finding cancer information pages (n=8; 
89%). 
“I had no hassle with it at all, and as I say having, you know I'm no(t) great on computers 
and things but I have some knowledge so I was able to do it” [ID18]. 
Seventy-eight per cent of patients (n=7) felt that the ASyMS-R questionnaire covered all 
relevant symptoms, and all (n=9) agreed that the handset helped them to both manage their 
symptoms and communicate with the doctors and nurses responsible for their care, 
irrespective of phase of treatment. 
“Well as far as I am concerned yes, because it was very helpful because I had this bad cough 
and one or two alerts came up and the nursing staff at the other end were immediately onto 
it... the fact that we were in contact with the hospital very much quicker than we would be if 
we’d waited and maybe even phoned” [ID51]. 
12 
Irrespective of phase of treatment, the majority of health professionals (n=10; 83%) also felt 
that the use of ASyMS-R resulted in earlier detection of problematic symptoms and timely 
interventions more often than with usual practice. 
Patients also expressed feelings of reassurance offered by ASyMS-R and the rapid feedback 
by health professionals in response to reported symptoms. 
“I think it’s a necessity almost, it just keeps your morale up and I think it’s a great little 
gadget. I’m glad, let me say I’m glad I had it and I’m glad I used it” [ID31]. 
Comments were also made on the way that ASyMS-R reduced the uncertainty experienced 
by the patients, particularly at times when they were at home and were unsure as to whether 
they should contact health professionals or not.  
“I was very pleased because once you’re away from the hospital and you needed contact with 
them you’re out on a limb sort of thing…..and you do tend to think “oh well perhaps this isn’t 
anything” and at least when you’re in contact with them (via ASyMS) they can, they know 
whether it is anything that’s necessary or not. So yes I quite agree with it, I’m glad that they 
were (there)” [ID51]. 
Corroborating these findings, health professionals also viewed positively having ‘real time’ 
access to the patient’s symptom reports on the ASyMS-R website following an alert, while 
having this information at hand prior to calling the patient enabled them to be better prepared: 
“… em, I think you, even in any situation so that you're, like a bit more prepared, em seeing 
what their, their issues are em, because they might have kind of forgotten what they put in to 
their questionnaire when you, when you phone them, em so it's just kind of saying you phoned 
and it makes them feel that you've actually … it's very individual to them you've taken the 
time to look, you've taken the time to prepare before you phone so you've got the knowledge, 
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and they don't need to go through everything again with you cause they might no [not] be 
feeling up to that” [SHP2]. 
Another area where patients provided positive feedback was the automated self-care advice 
generated by the ASyMS-R system; 89% of them (n=8) perceived the self-care advice offered 
easy to understand and user-friendly: 
“Oh it was helpful, yes … yes, that was helpful. Aye well the, the coughing and just to, 
reminding you to lie upright … upright, that was the thing you’re inclined to forget ….. you 
know to sort of eh, even sit up, up in bed … pillows up and eh coughing, and what was the 
other thing … ? breathless, breathless, instead of panicking, sometimes you could be inclined 
to, if you just let it get on top of you, and being reassured there that just, to do your breathing 
exercises which I had got in the hospital … and just relax, so that, that, that was good”[ID1]. 
Similarly, the majority of health professionals (n=9) also perceived the self-care advice as 
being a positive aspect which could help patients feel more empowered:  
“The best thing I think was the self-care advice because it's encouraging patients with their 
own health and to try things first cause that's what we would do for them anyway ... so I think 
it is putting the ball back in their court for their health em and you know trying that first and 
if they feel better after a self-help tip that they've done themselves, it gives them a bit of kind 
of encouragement to” [SHP2]. 
However, six patients admitted to never or only sometimes having read the self-care 
information pages, either during or after treatment. In the post-study interviews, some of the 
participants commented on how they were not trained on using this component of the system. 
Others commented on how they did not use the self-care information due to having received 
similar information from their health care professionals:  
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“Aye, I'll be honest about that, I scanned over it [self-care] because I was getting, I, I was 
getting the treatment for it, do you know I was doing, what I should have been doing kind of 
thing it wis'nae [was not] anything that was new to me” [ID18]. 
Importantly, professionals perceived the system to have most potential during the post-
treatment phase, when patients had to deal with the toxicities of their treatment with limited 
input from healthcare personnel: 
“I think there's quite good contact during radiotherapy. But where it falls down and this is 
where this device would be useful, I think, is after treatment; if patients are at home by 
themselves, nobody's is really asking them every day how they are feeling, what their 
symptoms are… I think that would be something to think about for the future” [PI2]. 
Despite seeing the utility of ASyMS-R in the delivery of timely interventions to people with 
lung cancer, half of the health professional sample (n=6) were unsure of the utility of 
ASyMS-R, or considered it as definitely unhelpful. One health professional spoke about how 
she found the system cumbersome due to having to use different pieces of equipment: 
“It takes the patient to key-in something and then for a nurse to respond to an additional 
piece of equipment that they have to carry apart from the equipment they already carry. It 
then depends on them picking that that alert up and then physically logging into another 
system in addition to the system they will always be logging into and then phoning the 
patient. So compared to the system that I'm used to, it seems cumbersome, it adds in too many 
other things to do to actually get to the patient.” [CNS1]. 
 
Secondary Aim: Change in Patient Outcomes 
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Patients reported moderate levels of anxiety both at baseline and at follow-up (Table 3). No 
differences in anxiety levels were found according to clinical or demographic variables at 
either pre- or post-study (all p’s >0.05). In addition, no significant between-time points 
differences were found for either state (Z=–0.42; p=0.68) or trait anxiety (Z=–0.25; p=0.80) 
before and after using the handset. 
Mean SUPPH-29 scores also indicated that patients were ‘somewhat confident’ in handling 
the effects of their disease and treatment at each time point. Again, no associations with 
demographic or clinical variables emerged (all p’s >0.05). Moreover, no significant 
differences were found between pre- and post-study data (all p’s >0.05); however, a slight 
improvement in mean scores was noted for ‘positive attitude’ and ‘making decisions’ 
subscales after use of the handset. 
Patient well-being was reported as overall good, especially the physical, social and emotional 
components, at either point of assessment; only scores on the functional well-being scale 
were relatively low. Patients scheduled to receive fewer radiotherapy fractions had poorer 
functional well-being (F=17.358; p=0.002); however, this association disappeared in the 
post-study assessment. Only a slight, yet not significant, improvement in patient functional 
well-being was noted during use of the ASyMS-R system (t=–1.54; p=0.12). 
Prevalence rates of moderate to severe symptoms at either point of assessment are shown in 
Table 3, with decreases found for fatigue, depression, anxiety, drowsiness, appetite and other 
problems, which were nevertheless not significant (all p’s >0.05). Wilcoxon Signed Rank 
tests revealed only a significant increase (Z=–2.03; p=0.04) in the levels of pain at post- 
treatment compared with baseline. 
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DISCUSSION 
This is the first study of its kind to report patients’ and health professionals’ perceptions of 
the feasibility and acceptability of the use of a mobile phone-based symptom monitoring 
system in patients with lung cancer receiving radiotherapy. Whilst the study sample is small, 
the findings suggest that the use of this type of technology is feasible and acceptable to 
patients with lung cancer. Participating patients perceived the use of ASyMS-R as a positive 
contribution to their care, particularly the real-time reporting of symptoms, the quick clinician 
response to alerts, and the reassurance that was evoked by the fact that clinicians were able to 
closely monitor patient symptoms even from a distance. These findings are supportive of 
similar positive evidence generated by previous ASyMS studies conducted among various 
patient populations with cancer
29, 30, 49
. One issue that emerged during the study related to 
reduced patient usability of one of the components of the ASyMS-R system, namely access 
and/or use of the automated self-care advice that followed receipt of a patient symptom 
questionnaire. Apart from the fact that patient training might have been sub-optimal in a few 
cases, a contributing factor to this problematic area could have been the availability of 
clinical advice to patients receiving active radiotherapy treatment, which might have led to 
this patient sample feeling that any additional symptom management information was 
redundant. However, self-care strategies have been advocated as an important concept in 
cancer care
50
, and past evidence demonstrates positive effects of self-care approaches in 
controlling symptoms
51-54
. In the context of the current study, prompt self-care advice and 
strategies can be used immediately after symptoms have been reported and while awaiting for 
clinician response and intervention, thus ultimately supporting patients’ sense of control and 
independence. 
17 
Health professionals’ perceptions of feasibility and acceptability of ASyMS-R were similarly 
positive, mainly in relation to the generation of ‘real-time’ clinical alerts and the self-care 
advice provided by the system. However, whilst most agreed that the alerting system was of 
clinical benefit and resulted in the timely management of symptoms, half of the clinicians 
were unsure of its clinical utility. Some of the negative perceptions seem to have occurred as 
a result of health professionals viewing ASyMS-R as an addition to their workload, or 
perhaps due to perceived ‘inappropriateness’ of the alerts generated. Such perceptions 
appeared to also stem from health professionals’ views on the ‘appropriateness’ of using 
ASyMS-R during radiotherapy treatment, when patients were in frequent contact with the 
clinical team. Although this may suggest that the system would be of greater benefit post-
radiotherapy treatment, such clinician perspectives seem to be contrary to those expressed by 
patients in this study. A similar comment can be made with regard to alert ‘appropriateness’ 
and the observed discrepancy in the views of patients and clinicians. The resource 
implications of the use of ASyMS-R in clinical practice were also raised, including the time 
taken to log patients onto the system, train patients in using the system, or deal with incoming 
alerts. According to the ‘Normalization Process Theory’55, the identification of factors that 
promote or inhibit routine embedding of interventions in everyday practice are fundamental 
to their future implementation. In that sense, the findings of this study provide insight into the 
future development and use of mobile technologies and key aspects for clinicians which 
should be considered in future studies. 
In terms of patient-reported outcomes, some clinically significant gain emerged, which can be 
cautiously linked to a hypothesized improved patient symptom management as a result of the 
use of the ASyMS-R system that boosted patients’ sense of control and confidence. This 
seemed to be particularly related to patients’ perceptions of their self-care self-efficacy, as 
well as to clinically significant symptom distress, especially with respect to patient anxiety 
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and drowsiness. Self-efﬁcacy, defined as the confidence in one’s ability to execute a course 
of action, has been regarded as an inﬂuential factor of the patients’ ability to self-manage 
their symptoms
56
 as it can determine how a person thinks, feels, motivates and performs. 
Zhang et al.
57
 argued that a sense of control and involvement in the treatment are important 
aspects of patient self-efficacy. Current evidence suggests that higher levels of patient self-
efﬁcacy in symptom management may be linked to less psychological distress58 and better 
adjustment in the long run
59
. In the current study, the absence of statistically significant 
changes may have been the result of different factors interfering with the data including (a) 
population-specific ceiling effects not allowing additional gain to be shown; (b) attrition, 
especially with such a small sample size, that might have been related to the more distressed 
patients withdrawing from the study; or (c) actual positive (e.g. dyspnea) or negative (e.g. 
well-being) radiotherapy effects that might have interfered with intervention effects. All of 
the issues addressed here will need to be re-evaluated in order to inform a future pilot study 
of a ‘pragmatic’ randomized controlled trial tailored to lung cancer care in line with current 
recommendations
60
. 
Our findings provide useful insight as to how ASyMS-R can be further developed for use in 
patients receiving radiotherapy. Future studies will need to include audio and visual resources 
within the self-care component, as this may provide patients with a greater array of self-care 
information in an interactive, accessible and easy to understand format. The use of these 
mediums in the delivery of self-care advice is widely reported in the literature, with positive 
perceptions and improved patient outcomes reported as a consequence of such 
interventions
61, 62
. Moreover, the restricted scope of the ASyMS-R system, focusing only on 
the toxicities associated with radiotherapy during and immediately after the treatment phase, 
may have limited its clinical utility. Patients with lung cancer receiving radiotherapy 
commonly experience toxicities several months post treatment
63
, are increasingly receiving 
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combined modality treatments
64
 and often have several other co-morbidities
65, 66
. Widening 
the scope of the system to allow for inclusion of additional time-points in the lung cancer 
treatment continuum, measurement of toxicities associated with combined cancer treatments, 
recognition and distinction of symptoms relating to co-morbidities, and evaluation of the 
wider supportive care needs of patients with lung cancer could render this system more 
appealing to health professionals in busy clinical settings. In conjunction with the afore-
mentioned developments, reducing the time clinicians will be required to spend on using the 
system possibly through use of adequately-sized smartphones that could act as both pagers 
and computer terminals to allow web access, as well as standardizing the protocols for 
clinician intervention following an alert could further enhance the system’s clinical utility. 
 
Strengths and Limitations 
Although this study is to our knowledge one of the first to explore the use of mobile 
technology in the remote monitoring and reporting of radiotherapy-related toxicity in people 
with lung cancer, the results should be interpreted with some caution given the small sample 
size, the observed attrition, and lack of a control group. In addition, our findings may be 
associated more with the characteristics of this specific sample rather those of the lung cancer 
patient population. For instance, lack of familiarity with technology might have deterred 
patients from taking part in this study. Furthermore, it remains to be verified whether the 
observed fluctuations in patient outcomes reflect true intervention effects or simply the 
natural course of change post-administration of radiation therapy. What is more, the follow-
up evaluation included one post-treatment measurement only, which may have compromised 
our sensitivity in documenting changes over time in patient-reported outcomes. Addition of 
intermediate measurements might have allowed for a more detailed investigation of over-time 
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change, and revealed significant intervention effects manifested earlier in the course of 
radiotherapy. 
 
CONCLUSIONS 
This study demonstrated the potential to provide an accurate and acceptable means of 
radiotherapy-related toxicity assessment and management in clinical practice, thus effectively 
responding to the needs of patients with lung cancer and facilitating the delivery of timely 
interventions. Patients with lung cancer perceived the ASyMS-R system to positively impact 
on their care and promote the timely reporting and management of their symptoms. Health 
professionals involved in the care of patients with lung cancer perceived the use of ‘real-time’ 
risk algorithms and automated self-care advice as being positive aspects of such systems. 
Future research will be required to enhance the properties of the system, expand the use of 
this technology to the post-radiotherapy period, and widen the scope of the system to 
encompass a wider range of supportive care needs of people with lung cancer. 
21 
Statement of Authorship: All authors have equally contributed to the preparation of this 
manuscript. 
Conflicts of interest: The authors have no personal or financial conflicts of interest to 
disclose.
22 
FIGURE LEGENDS 
Figure 1. Conceptual diagram of the ASyMS-R intervention for patients with lung cancer 
receiving radiotherapy treatment. 
Figure 2. Example scenario of clinician involvement in handling a red alert generated by 
pain graded at ‘quite a bit’. 
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TABLES 
Table 1. Working principles of the Holistic Framework for the Uptake and Impact of e-Health 
Technologies
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Principle Concept 
1. e-Health Technology Development is 
a Participatory Process 
“Stakeholder participation is essential. Stakeholders’ involvement spans the full 
development process, starting from contextual inquiry and ending with 
summative evaluation.” 
2. e-Health Technology Development 
Involves Continuous Evaluation 
Cycles 
“Development is an iterative, flexible, and dynamic process resulting in 
concepts of the technology (from ideation to prototypes). […] Evaluation as 
such is a cyclic, longitudinal research activity interwoven with all stages in the 
development process and as such without a fixed end (formative and summative 
evaluation.” 
3. e-Health Technology Development is 
Intertwined With Implementation 
“…the conditions for implementation must be taken into account right from the 
start (contextual inquiry and value specification.” 
4. e-Health Technology Development 
Changes the Organization of Health 
Care 
“The development of e-Health technology in itself can be considered as the 
creation of new processes and infrastructures for health care delivery. It may 
reshape health care since it intervenes with traditional care characteristics such 
as the division of labor, or time- and place-dependant deliver.” 
5. e-Health Technology Development 
Should Involve Persuasive Design 
Techniques 
“[Patients] expect self-care technology to show understanding, to persuade them 
to do the right thing, or to provide rewards and appraisal for appropriate 
behavior. […] Particularly in the context of long-term care, it is important to 
develop technologies that can create bonding relationships with the end users. 
[…] Via persuasive techniques, e-Health technologies can be designed to match 
user profiles, and to motivate or inspire patients to engage in self-management.” 
6. e-Health Technology Development 
Needs Advanced Methods to Assess 
Impact 
“…need to understand what differences e-Health technologies can make in 
health care, why e-Health technologies make these differences, and why e-
Health technologies may not have the expected impact. […] The challenge lies 
in the integration of data collection from multiple sources, using a mixed-
methods research design.” 
 
 
Tables 1-3
Table 2. Examples of alerts generated by the ASyMS-R system for different MSAS-SF and RSC-
Activity symptom items based on grading of symptom frequency/severity/distress 
Symptom Graded as/at Condition for alert to be 
triggered 
Type of alert to 
be triggered 
Coughing up blood ‘Not happened before’ AND 
‘more than a few teaspoons of 
blood’ 
Always triggered Red 
Pain ‘Quite a bit’ OR ‘Very much’ Always triggered Red 
Shortness of breath ‘Quite a bit’ OR ‘Very much’ Always triggered Red 
Flu-like symptoms ‘Quite a bit’ OR ‘Very much’ Always triggered Red 
Coughing up blood ‘Not happened before’ Always triggered Amber 
Coughing up blood ‘Happened before’ AND ‘more 
than two teaspoons of blood’ 
Always triggered Amber 
Pain ‘Somewhat’ Always triggered Amber 
Shortness of breath ‘Somewhat’ Always triggered Amber 
Flu-like symptoms ‘Somewhat’ Always triggered Amber 
Other symptoms (e.g. cough, 
nausea, lack of appetite, sore 
throat) 
‘Quite a bit’ OR ‘Very much’ Always triggered Amber 
Feeling anxious ‘Somewhat’ 72 hours or more Amber 
Heartburn ‘Somewhat’ 48 hours or more Amber 
Any ‘new’ symptom ‘Quite a bit’ OR ‘Very much’ Always triggered Amber 
Abbreviations: MSAS-SF – Memorial Symptom Assessment Scale-Short Form; RSC-Activity – Rotterdam Symptom Checklist-Activity 
subscale. 
 
 
Table 3. Baseline and post-treatment outcome scores, and between time-points associations 
Outcome Subscale 
Cronbach’s 
alpha 
Baseline (n=15) Post-treatment (n=11) 
M SD Range M SD Range 
STAI-Y state 0.63 43.9 9.0 23-61† 46.4a 5.1 38-54 
STAI-Y trait 0.62 43.0b 8.3 23-53 44.9c 5.3 33.51 
SUPPH29 Positive 
attitude 
0.70 48.1d 16.1 17-80
ǂ  56.1e 14.6 31-76 
SUPPH29 Stress 
reduction 
0.65 27.4b 10.9 13-50 26.6 9.4 16-42 
SUPPH29 Making 
decisions 
0.72 8.4b 4.0 2-15 9.4 3.7 3-14 
FACT-L PWB 0.74 19.7 6.5 6-27
§
 17.4 6.2 3-25 
FACT-L SWB 0.69 18.6 4.0 12-24 17.1 4.0 10-22 
FACT-L EWB 0.70 16.6 6.4 3-24 16.5 6.6 5-24 
FACT-L FWB 0.73 12.0 7.8 2-26 14.6 6.6 8-25 
FACT-L LCS 0.72 21.2 6.7 10-32 19.6 7.1 8-32 
FACT-L Total 0.68 86.2 24.7 36-125 85.1 21.6 53-120 
FACT-L TOI 0.73 52.1 17.8 18-80 51.6 15.5 20-74 
 
Cronbach’s 
alpha 
Baseline (n=14) Post-treatment (n=10) 
MDN Range > 4
 
(%)
* 
MDN Range > 4
 
(%) 
ESAS Pain 0.68** 1.5 0-7$ 21.4 4 0-8 20.0 
ESAS Tiredness  5 1-8 57.1 4 0-9 50.0 
ESAS Nausea  0 0-8 7.1 2 0-6 20.0 
ESAS Depression  0 0-8 14.2 0 0-8 10.0 
ESAS Anxiety  0.5 0-10 28.5 1 0-8 10.0 
ESAS Drowsiness  3.5 0-9 42.9 3 0-8 20.0 
ESAS Appetite  5 0-10 57.1 4f 0-10 44.4 
ESAS Well-being  4.5 0-10 50.0 4.5 0-7 50.0 
ESAS Breathlessness  3.5 0-9 35.7 3 0-9 30.0 
ESAS Other problem  0e 0-6 40.0 0g 0-7 16.7 
Abbreviations: ESAS – Edmonton Symptom Assessment Scale; EWB – emotional w/b subscale; FACT-L Total – sum of all 5 subscales; 
FWB – functional w/b subscale; LCS – lung cancer specific w/b subscale; M – Mean; MDN – Median; PWB – physical w/b subscale; SD 
– Standard Deviation; STAI-Y – State/Trait Anxiety Inventory Form Y; SUPPH29 – Strategies Used by Patients to Promote Health 29; 
SWB – social w/b subscale; TOI – Total outcome index (sum of PWB, FWB, LCS); w/b – Well-being. 
* A score >4 indicates increased symptom distress and warrants intervention. 
** Cronbach’s alpha was calculated for the total ESAS. 
† Possible range of scores: 20-80 
ǂ
 Possible range of scores: PA 15-75, SR 10-50, MD 3-15 
§
 Possible range of scores: PWB 0-28, SWB 0-28, EWB 0-24, FWB 0-28, LCS 0-40, TFACT-L 0-148, TOI 0-96. 
$ Possible range for all scales 0-10 
a n=11; b n=13; c n=8; d n=14; e n=10; f n=9; g n=6 
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